Elevated IGFBP-2 Levels in Children with Acute Leukaemia
Author Information
Author(s): H Wexl, P Vorwerk, K Mohnike, D Bretschneider, U Kluba, V Aumann, WF Blum, U Mittler
Primary Institution: Otto-von-Guericke University Magdeburg
Hypothesis
Does elevated serum IGFBP-2 in children with acute leukaemia indicate tumor expression and potential relapse risk?
Conclusion
The study concluded that elevated serum IGFBP-2 levels in children with acute leukaemia are primarily due to tumor expression.
Supporting Evidence
- IGFBP-2 serum levels were significantly elevated in ALL patients compared to control groups.
- 72% of ALL patients had detectable IGFBP-2 mRNA at diagnosis.
- IGFBP-2 levels normalized during chemotherapy.
Takeaway
Kids with a type of blood cancer have higher levels of a protein called IGFBP-2, which comes from their tumors and can help doctors understand their condition better.
Methodology
Serum levels of IGFBP-1, -2, and -3 were measured in children with acute lymphoblastic leukaemia and compared to control groups, along with gene expression analysis using RT-PCR.
Limitations
The study may not account for other sources of IGFBP-2 in serum, such as liver production.
Participant Demographics
Children aged 1.1 to 16.3 years with acute lymphoblastic leukaemia.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website